In the Green: Astria Therapeutics Inc (ATXS) Closes at $12.91, Up/Down -0.46% from Previous Day

Ulysses Smith

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

In the latest session, Astria Therapeutics Inc (NASDAQ: ATXS) closed at $12.91 down -0.46% from its previous closing price of $12.97. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 1.06 million shares were traded. ATXS stock price reached its highest trading level at $13.04 during the session, while it also had its lowest trading level at $12.89.

Ratios:

For a deeper understanding of Astria Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.78 and its Current Ratio is at 10.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

On September 17, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $16 to $20. On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $47.Cantor Fitzgerald initiated its Overweight rating on April 29, 2025, with a $47 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 736965248 and an Enterprise Value of 609027264. For the stock, the TTM Price-to-Sale (P/S) ratio is 1037.98 while its Price-to-Book (P/B) ratio in mrq is 5.28. Its current Enterprise Value per Revenue stands at 862.645.

Stock Price History:

The Beta on a monthly basis for ATXS is 0.02, which has changed by 0.35609245 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, ATXS has reached a high of $13.29, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is 9.56%, while the 200-Day Moving Average is calculated to be 75.09%.

Shares Statistics:

For the past three months, ATXS has traded an average of 1.94M shares per day and 1516940 over the past ten days. A total of 56.43M shares are outstanding, with a floating share count of 49.96M. Insiders hold about 12.49% of the company’s shares, while institutions hold 76.68% stake in the company. Shares short for ATXS as of 1764288000 were 4813071 with a Short Ratio of 2.48, compared to 1761868800 on 3143418. Therefore, it implies a Short% of Shares Outstanding of 4813071 and a Short% of Float of 10.5900005.

Earnings Estimates

The firm’s stock currently is rated by 3 analysts. The consensus estimate for the next quarter is -$0.6, with high estimates of -$0.54 and low estimates of -$0.65.

Analysts are recommending an EPS of between -$2.0 and -$2.26 for the fiscal current year, implying an average EPS of -$2.12. EPS for the following year is -$2.36, with 4.0 analysts recommending between -$2.01 and -$2.75.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.